Inventor · disambiguated record
Yu Miao
Also filed as: MIAO YU · MIAO YU REBECCA
8 granted patents·13 pending applications·47 citations·filing 2012–2025
85Inventor score
Files withUNIV LELAND STANFORD JUNIOR13SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD3GIACCIA AMATO J2AKSO BIOPHARMACEUTICAL INC1ARAVIVE BIOLOGICS INC1
Top patents by PatentIndex Score
21 records- 0191US8618254B2Inhibition of AXL signaling in anti-metastatic therapyGIACCIA AMATO J·Filed 2012·Granted Dec 31, 2013·25 cites·8 claims
- 0288US9074192B2Inhibition of AXL signaling in anti-metastatic therapyGIACCIA AMATO J·Filed 2012·Granted Jul 7, 2015·7 cites·7 claims
- 0383US9879061B2Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosisUNIV LELAND STANFORD JUNIOR·Filed 2012·Granted Jan 30, 2018·4 cites·4 claims
- 0479US11136563B2Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Oct 5, 2021·1 cites·6 claims
- 0579US10876176B2Antifibrotic activity of GAS6 inhibitorARAVIVE BIOLOGICS INC·Filed 2015·Granted Dec 29, 2020·2 cites·4 claims
- 0679US9266947B2Inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Feb 23, 2016·4 cites·6 claims
- 0778US9822347B2Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapyUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Nov 21, 2017·3 cites·3 claims
- 0875US11498955B2SPD-1 variant# FC fusion proteinsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Nov 15, 2022·1 cites·38 claims
- 0969US2022220458A1Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic TherapyUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 1069US2025346606A1Camptothecin compound, preparation method therefor, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1165US2023131056A1sPD-1 VARIANT – FC FUSION PROTEINSUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 1263US2024158410A1Camptothecin compound, preparation method therefor, and application thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1363US2024325239A1Device for treating orthostatic syncope and methods thereofUNIV DUKE·Filed 2024·Application pending·0 cites
- 1456US2025115657A1Bispecific FC Fusion Proteins with sPD-1 and IL-15AKSO BIOPHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 1553US2024269312A1Antibody drug conjugate, and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1651US2018094034A1Inhibition of axl/gas6 signaling in the treatment of liver fibrosisUNIV LELAND STANFORD JUNIOR·Filed 2017·Application pending·0 cites
- 1748US2024294604A1sBCMA Variants and FC Fusion Proteins ThereofUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 1847US2015315552A1Inhibition of AXL Signaling in Primary Tumor TherapyUNIV LELAND STANFORD JUNIOR·Filed 2013·Application pending·0 cites
- 1947US2016266136A1High-affinity binding to gas6UNIV LELAND STANFORD JUNIOR·Filed 2013·Application pending·0 cites
- 2047US2016108378A1Inhibition of AXL Signaling in Anti-Metastatic TherapyUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
- 2147US2018140679A1Modulation of axl receptor activity in combination with cytoreductive therapyUNIV LELAND STANFORD JUNIOR·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu Miao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →